-
2022-501538-44-00
5
2023-04-25
Atopic Dermatitis
-
2023-505540-19-00
10
2023-04-24
Pulmonary Hypertension Associated with Interstitial Lung Disease
-
2022-501246-30-00
6
2023-03-08
Insomnia Disorder
-
2024-512590-27-00
9
2023-03-08
Non-resectable locally advanced or metastatic HER2-positive breast can
-
2024-515744-23-00
1
2023-02-15
Relapsed or refractory (R/R) Acute lymphoblastic leukemia (ALL), R/R A
-
2024-514761-19-00
5
2023-01-25
Idiopathic Pulmonary Fibrosis
-
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
-
2024-512803-37-00
5
2022-10-05
Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
-
2023-505458-16-00
5
2022-09-13
Gastric and Gastroesophageal Junction Cancer With FGFR2b Overexpressio
-
2024-513992-42-00
10
2022-09-13
venous thromboembolism (VTE) in patients with gastrointestinal/genitou
-
2024-514293-46-00
4
2022-07-07
Unresectable locally advanced or metastatic urothelial cancer
-
2023-505541-99-00
4
2022-06-28
Pulmonary Arterial Hypertension
-
2024-518403-22-00
6
2022-06-20
Diabetes mellitus II
-
2024-519691-10-00
6
2022-05-27
Septic Shock
-
2024-511263-28-00
6
2022-04-08
Hypercholesterolemia
-
2023-503756-27-00
4
2022-03-31
Non-Small Cell Lung Cancer (NSCLC)
-
2023-508828-35-01
5
2022-03-28
Patients with advanced hormone receptor-positive/HER2- negative/HER2-E
-
2024-512108-20-00
5
2022-03-16
Obsessive Compulsive Disorder
-
2023-508213-16-00
4
2022-03-15
Multiple Myeloma
-
2024-518875-73-00
5
2021-12-10
Huntington Disease
-
2024-512052-38-00
9
2021-12-02
Advanced triple negative breast cancer
-
2022-500752-39-00
5
2021-11-25
Prevention of Respiratory syncytial virus (RSV) infection in infants a
-
2024-512880-30-00
5
2021-08-27
Neovascular Age-related Macular Degeneration (wet AMD)
-
2022-501342-29-00
5
2021-07-21
Esophageal Carcinoma